Credit Suisse’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2.09M | Sell |
316,693
-22,957
| -7% | -$152K | ﹤0.01% | 1826 |
|
|
2023
Q4 | $1.54M | Sell |
339,650
-509
| -0.1% | -$2.3K | ﹤0.01% | 2052 |
|
|
2023
Q3 | $1.22M | Sell |
340,159
-59,029
| -15% | -$211K | ﹤0.01% | 2153 |
|
|
2023
Q2 | $1.47M | Buy |
399,188
+165,775
| +71% | +$612K | ﹤0.01% | 2115 |
|
|
2023
Q1 | $773K | Buy |
233,413
+10,347
| +5% | +$34.2K | ﹤0.01% | 2460 |
|
|
2022
Q4 | $865K | Buy |
223,066
+222,001
| +20,845% | +$861K | ﹤0.01% | 2428 |
|
|
2022
Q3 | $3K | Buy |
1,065
+974
| +1,070% | +$2.74K | ﹤0.01% | 3644 |
|
|
2022
Q2 | $0 | Buy |
+91
| New | – | ﹤0.01% | 3864 |
|
|
2021
Q4 | – | Sell |
-35,000
| Closed | -$40K | – | 3611 |
|
|
2021
Q3 | $40K | Buy |
+35,000
| New | +$40K | ﹤0.01% | 3485 |
|
|
2021
Q2 | – | Sell |
-18,328
| Closed | -$32K | – | 3564 |
|
|
2021
Q1 | $32K | Buy |
18,328
+3,694
| +25% | +$6.45K | ﹤0.01% | 3382 |
|
|
2020
Q4 | $28K | Buy |
+14,634
| New | +$28K | ﹤0.01% | 3430 |
|
|
2019
Q4 | – | Sell |
-12,162
| Closed | -$54K | – | 3464 |
|
|
2019
Q3 | $54K | Buy |
+12,162
| New | +$54K | ﹤0.01% | 3351 |
|